PYC Therapeutics Investor Relations Material
Latest events
Q2 2025
PYC Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from PYC Therapeutics Limited
Access all reports
PYC Therapeutics Limited is an Australia-based biotechnology company focused on developing RNA-based therapies to treat genetic diseases. The company specializes in precision medicine, leveraging its RNA therapeutic platform to design and deliver drugs targeting the root causes of genetic disorders. PYC Therapeutics is involved in preclinical and clinical development, with a focus on rare inherited diseases, particularly those affecting vision and the central nervous system. The company is headquartered in Perth, Western Australia, and its shares are listed on the ASX.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
PYC
Country
🇦🇺 Australia